Related Experiment Video
Updated: Dec 9, 2025

13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
136.7K
Evaluation of malignancy risk in scleroderma by antibody profile
C Lertphanichkul1,2, G P Smith1
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
The British Journal of Dermatology
|September 13, 2020
Abstract
No abstract available in PubMed .

